Manulife (Manufacturers Life Insurance)
IMNM icon

Manulife (Manufacturers Life Insurance)’s Immunome IMNM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.52M Sell
206,799
-30,471
-13% -$678K ﹤0.01% 1188
2025
Q4 		$5.03M Sell
237,270
-53,172
-18% -$933K ﹤0.01% 1163
2025
Q3 		$3.4M Buy
290,442
+9,626
+3% +$95.8K ﹤0.01% 1327
2025
Q2 		$2.61M Buy
280,816
+9,686
+4% +$79.4K ﹤0.01% 1397
2025
Q1 		$1.82M Buy
271,130
+82,070
+43% +$787K ﹤0.01% 1526
2024
Q4 		$2.01M Buy
189,060
+23,569
+14% +$285K ﹤0.01% 1555
2024
Q3 		$2.42M Sell
165,491
-1,437
-0.9% -$20.4K ﹤0.01% 1484
2024
Q2 		$2.02M Buy
166,928
+57,242
+52% +$895K ﹤0.01% 1494
2024
Q1 		$2.71M Buy
109,686
+55,940
+104% +$1.14M ﹤0.01% 1412
2023
Q4 		$575K Hold
53,746
– – ﹤0.01% 2116
2023
Q3 		$449K Buy
+53,746
New +$395K ﹤0.01% 2185

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IMNM Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Immunome (IMNM) stake by 13% in Q1 2026, selling an estimated $678K and leaving 206,799 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Manulife (Manufacturers Life Insurance) first reported a position in IMNM in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.03M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 206,799 shares of Immunome worth $4.52M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 30,471 Immunome shares in Q1 2026, an estimated $678K.
  • Immunome made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1188 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Immunome in Q3 2023 and has held it in 11 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Immunome position peaked at $5.03M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.